Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

Podrobná bibliografie
Hlavní autoři:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
Médium:	Journal article
Jazyk:	English
Vydáno:	Springer Nature 2020

Podobné jednotky

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Autor: Yasunori Watanabe, a další
Vydáno: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
Autor: Watanabe, Y, a další
Vydáno: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
Autor: Crispin, M, a další
Vydáno: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
Autor: Crispin, M, a další
Vydáno: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
Autor: Seabright, GE
Vydáno: (2019)

Beyond Shielding: The Roles of Glycans in the SARS-CoV‑2 Spike Protein
Autor: Lorenzo Casalino, a další
Vydáno: (2020-09-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
Autor: Pritchard, L, a další
Vydáno: (2015)

Architecture of the HIV-1 glycan shield
Autor: Pritchard, L
Vydáno: (2014)

Mapping the glycan shields of enveloped viruses
Autor: Watanabe, Y
Vydáno: (2020)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
Autor: Behrens, AJ, a další
Vydáno: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
Autor: Joel D. Allen, a další
Vydáno: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
Autor: Bonomelli, C, a další
Vydáno: (2011)

Glycosylator: a Python framework for the rapid modeling of glycans
Autor: Thomas Lemmin, a další
Vydáno: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
Autor: Amr Sobhi Gouda, a další
Vydáno: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Autor: Le, N, a další
Vydáno: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
Autor: Camille Bonomelli, a další
Vydáno: (2011-01-01)

Fine structure of the HIV-1 glycan shield
Autor: Behrens, A
Vydáno: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
Autor: Weiwei Peng, a další
Vydáno: (2022-08-01)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
Autor: Mingjun Yang, a další
Vydáno: (2017-06-01)

Glycan Nanostructures of Human Coronaviruses
Autor: Guo W, a další
Vydáno: (2021-07-01)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
Autor: Sommerstein, R, a další
Vydáno: (2015)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
Autor: Rami Sommerstein, a další
Vydáno: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
Autor: Rising, T, a další
Vydáno: (2006)

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
Autor: Parham Jabbarzadeh Kaboli, a další
Vydáno: (2025-02-01)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
Autor: Mihaela-Olivia Dobrica, a další
Vydáno: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
Autor: Marie-Estelle Losfeld, a další
Vydáno: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
Autor: Julien J, a další
Vydáno: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
Autor: Qing Wei, a další
Vydáno: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
Autor: Bénédicte Machiels, a další
Vydáno: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
Autor: Esteban Cruz, a další
Vydáno: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Autor: Naveen Vankadari, a další
Vydáno: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Autor: Pejchal, R, a další
Vydáno: (2011)

Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology
Autor: Jonathan J Lyons, a další
Vydáno: (2015-06-01)

Multivalent interactions between fully glycosylated influenza virus hemagglutinins mediated by glycans at distinct N-glycosylation sites
Autor: Ruofan Li, a další
Vydáno: (2024-10-01)

Fine structure of the HIV-1 glycan shield - Supplementary information
Autor: Behrens, A
Vydáno: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
Autor: Tongqing Zhou, a další
Vydáno: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
Autor: Muriel Lavie, a další
Vydáno: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
Autor: Pritchard, L, a další
Vydáno: (2015)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
Autor: Rajesh P Ringe, a další
Vydáno: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
Autor: Davis, B, a další
Vydáno: (2000)